[
  {
    "ts": null,
    "headline": "Jefferies Initiates Coverage of Steris (STE) with ‘Hold’ Rating and $263 Price Target",
    "summary": "Jefferies initiated coverage of Steris PLC (NYSE:STE) on May 28 with a ‘Hold’ rating and a $263 price target. The research firm reiterated that the company could come under pressure due to the risk of over 14 million Medicaid and Health Insurance individuals losing coverage. Jefferies expects STERIS to grow revenue by 8% in 2026, […]",
    "url": "https://finnhub.io/api/news?id=c78d6392f19a36aebdd195e407f1f3b1d2670935e32e716e2811983842e79bd2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748539976,
      "headline": "Jefferies Initiates Coverage of Steris (STE) with ‘Hold’ Rating and $263 Price Target",
      "id": 134855994,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STE",
      "source": "Yahoo",
      "summary": "Jefferies initiated coverage of Steris PLC (NYSE:STE) on May 28 with a ‘Hold’ rating and a $263 price target. The research firm reiterated that the company could come under pressure due to the risk of over 14 million Medicaid and Health Insurance individuals losing coverage. Jefferies expects STERIS to grow revenue by 8% in 2026, […]",
      "url": "https://finnhub.io/api/news?id=c78d6392f19a36aebdd195e407f1f3b1d2670935e32e716e2811983842e79bd2"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons to Avoid STE and 1 Stock to Buy Instead",
    "summary": "In a sliding market, STERIS has defied the odds, trading up to $245 per share. Its 11.8% gain since November 2024 has outpaced the S&P 500’s 2.5% drop. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
    "url": "https://finnhub.io/api/news?id=419ce837df4dfe7d04d202393923be1a64be5229bebee1bc2f589d21af988fc1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748491353,
      "headline": "3 Reasons to Avoid STE and 1 Stock to Buy Instead",
      "id": 134813392,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STE",
      "source": "Yahoo",
      "summary": "In a sliding market, STERIS has defied the odds, trading up to $245 per share. Its 11.8% gain since November 2024 has outpaced the S&P 500’s 2.5% drop. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
      "url": "https://finnhub.io/api/news?id=419ce837df4dfe7d04d202393923be1a64be5229bebee1bc2f589d21af988fc1"
    }
  }
]